Evidence map›Paper›PMID 28413392›Full record

ArticleCase reports in oncology

T-Cell Lymphoma in a Patient with Neurofibromatosis Type 1 and AIDS.

Izana Junqueira de Castro, Esther Botelho Soares da Silva, Talita Rezende Dos Santos, Amanda Barroso de Freitas, Inara Junqueira de Castro, Alessandra Santos Portela, Marilza Campos de Magalhães, Karina Lebeis Pires, Guilherme Almeida Rosa da Silva, Marcelo Costa Velho Mendes de Azevedo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Izana Junqueira de CastroUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Esther Botelho Soares da SilvaUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Talita Rezende Dos SantosUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Amanda Barroso de FreitasUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Inara Junqueira de CastroUnião das Faculdades dos Grandes Lagos (UNILAGO), São José do Rio Preto, Brazil.
Alessandra Santos PortelaUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Marilza Campos de MagalhãesUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Karina Lebeis PiresUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Guilherme Almeida Rosa da SilvaUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Marcelo Costa Velho Mendes de AzevedoUniversidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Universidade Federal do Estado do Rio de Janeiro · BRFaculdade Ceres · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) and AIDS are risk factors for the development of malignant neoplasms, including hematological malignancies, such as non-Hodgkin lymphoma. NF1 is an autosomal dominant disease that primarily manifests as café-au-lait spots, dermal neurofibromas, axillary and/or inguinal ephelides or freckles, plexiform neurofibromas, Lisch nodules, and bone deformities. In this report, we present a 38-year-old female patient with NF1 from childhood and AIDS who developed peripheral T-cell lymphoma with good response to chemotherapeutic treatment.

Indexed as

AIDSHIVNeurofibromatosis type 1T-cell lymphoma

Identifiers

PMID28413392
PMCPMC5346920
OpenAlexW2588326907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.